Please sign in to follow a disease.
New study to track severe joint infections in ICU patients
NCT ID NCT06627842
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at patients in intensive care who have an infection in a joint replacement (like a hip or knee). Researchers want to understand their care path, recovery, and survival over two years. The study will collect data from medical records and phone calls with patients or their families.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand how to treat and manage severe joint infections in intensive care, potentially improving patient outcomes.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test any new therapy. Results may not apply to all hospitals or patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2025
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Critical care patients (intensive care and continuing care), admitted between 2018 and 2022 with a principal or associated diagnosis of prosthetic joint infection.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient at least 18 years old. * Hospitalization in critical care (intensive care unit or continuing care unit) between 2018 and 2022 of at least 48 hours, with prosthetic joint infection (hip, knee or shoulder prosthesis infection) as the main or associated diagnosis. Exclusion Criteria: * Infection on osteosynthesis material * Infection on spinal equipment * Patient with several infected prostheses * Recurrence of infection on prosthesis with the same microorganism * Patient opposing data collection * Patient under legal protection. * Pregnant or breast-feeding patient. * Patient deprived of liberty.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Intensive care patients are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hôpital Lariboisière
Paris, France, 75010, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Joint infection study asks: how much does it cost your daily life?
- Can a simple grip test predict joint replacement recovery?
- Friendly bacteria may fight off repeat joint infections
- Can a model predict the right dose of rifampicin for bone infections?
- Could a natural compound in food help beat knee implant infections?
- Antibiotic-Infused bone graft could slash infection risk in hip replacements